Certified by Founder Lodge
Northpond Ventures
United States - Bethesda, Maryland
INVESTOR
1 Disclosed Funding Rounds $100,000,000
46 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Northpond Ventures is a multi-billion dollar science-driven venture capital firm based in Cambridge, MA; San Francisco, CA; and Bethesda, MD. Northpond has been named one of the three most ac
| Company | Date | Round | Raised |
|---|---|---|---|
 Faro Health Inc. |
February, 16 ,2023 | Unknown | $20,000,000 |
 Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
 VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
 CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
 Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
 Triumvira Immunologics, Inc. |
March, 17 ,2022 | Series A | $100,000,000 |
 Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
 Delfi Diagnostics |
July, 18 ,2022 | Series B | $225,000,000 |
 Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
 Molecule |
July, 01 ,2022 | Seed | $12,700,000 |
 Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 DNAnexus |
June, 09 ,2022 | Unknown | $100,000,000 |
 EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
 Inflammatix, Inc. |
September, 13 ,2024 | Series E | $57,000,000 |
| Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
| Faro Health Inc. |
February, 16 ,2023 | Unknown | $20,000,000 |
 QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
| VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
| Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
| Triumvira Immunologics, Inc. |
March, 17 ,2022 | Series A | $100,000,000 |
 Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
| Selux Diagnostics, Inc |
March, 01 ,2022 | Series C | $50,000,000 |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
| Inflammatix, Inc. |
September, 13 ,2024 | Series E | $57,000,000 |
| Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
| VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
| EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
| Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
| Kyverna Therapeutics |
August, 03 ,2023 | Series B | $60,000,000 |
| EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
| QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
| QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
| Aro Biotherapeutics |
November, 29 ,2023 | Series B | $41,500,000 |
| Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
| Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
 Culture Biosciences |
December, 17 ,2025 | Series C | |
| Elephas |
January, 24 ,2024 | Series C | $55,000,000 |
| Inflammatix, Inc. |
September, 13 ,2024 | Series E | $57,000,000 |
| VieCure |
October, 02 ,2024 | Unknown | $45,000,000 |
| Eleanor Health |
October, 08 ,2024 | Series D | $30,000,000 |
| EnPlusOne Biosciences |
February, 21 ,2025 | Unknown | $10,000,000 |
| QbDVision |
May, 02 ,2025 | Unknown | $13,000,000 |
| Outcomes4Me |
May, 30 ,2025 | Unknown | $21,000,000 |
| Culture Biosciences |
December, 17 ,2025 | Series C |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
